258 related articles for article (PubMed ID: 37857256)
1. Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification.
Brewitz L; Henry Chan HT; Lukacik P; Strain-Damerell C; Walsh MA; Duarte F; Schofield CJ
Bioorg Med Chem; 2023 Nov; 95():117498. PubMed ID: 37857256
[TBL] [Abstract][Full Text] [Related]
2. Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).
Gold IM; Reis N; Glaser F; Glickman MH
Semin Cell Dev Biol; 2022 Dec; 132():16-26. PubMed ID: 35764457
[TBL] [Abstract][Full Text] [Related]
3. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
[TBL] [Abstract][Full Text] [Related]
4. SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.
Békés M; Rut W; Kasperkiewicz P; Mulder MP; Ovaa H; Drag M; Lima CD; Huang TT
Biochem J; 2015 Jun; 468(2):215-26. PubMed ID: 25764917
[TBL] [Abstract][Full Text] [Related]
5. UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.
Lin J; Ai Y; Zhou H; Lv Y; Wang M; Xu J; Yu C; Zhang H; Wang M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150874
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
Bailey-Elkin BA; Knaap RC; Johnson GG; Dalebout TJ; Ninaber DK; van Kasteren PB; Bredenbeek PJ; Snijder EJ; Kikkert M; Mark BL
J Biol Chem; 2014 Dec; 289(50):34667-82. PubMed ID: 25320088
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal roles of SARS-CoV PL
Yan S; Wu G
FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
[TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
[TBL] [Abstract][Full Text] [Related]
9. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin.
Lei J; Hilgenfeld R
Virol Sin; 2016 Aug; 31(4):288-99. PubMed ID: 27245450
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
11. Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2' proline of the viral polyprotein.
Chan HTH; Brewitz L; Lukacik P; Strain-Damerell C; Walsh MA; Schofield CJ; Duarte F
RSC Chem Biol; 2024 Feb; 5(2):117-130. PubMed ID: 38333195
[TBL] [Abstract][Full Text] [Related]
12. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
[TBL] [Abstract][Full Text] [Related]
13. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
Moghadasi SA; Moraes SN; Harris RS
J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules:
Pitsillou E; Liang J; Hung A; Karagiannis TC
Chem Phys Lett; 2021 May; 771():138468. PubMed ID: 33716308
[TBL] [Abstract][Full Text] [Related]
16. Structural and Biochemical Characterization of Porcine Epidemic Diarrhea Virus Papain-Like Protease 2.
Chu HF; Cheng SC; Sun CY; Chou CY; Lin TH; Chen WY
J Virol; 2022 Jan; 96(1):e0137221. PubMed ID: 34643430
[TBL] [Abstract][Full Text] [Related]
17. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
18. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro.
Große M; Setz C; Rauch P; Auth J; Morokutti-Kurz M; Temchura V; Schubert U
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891385
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of SARS-CoV-2 papain-like protease inhibitors.
Jadhav P; Huang B; Osipiuk J; Zhang X; Tan H; Tesar C; Endres M; Jedrzejczak R; Tan B; Deng X; Joachimiak A; Cai J; Wang J
Eur J Med Chem; 2024 Jan; 264():116011. PubMed ID: 38065031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
